BNS vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Bank of Nova Scotia (BNS) exhibits a weak financial health profile with a Piotroski F-Score of 2/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the stock shows strong recent earnings growth (YoY EPS +58.2%) and a robust dividend yield of 4.28%, supported by a high but sustainable payout ratio. Valuation metrics suggest the stock is trading slightly above analyst targets ($74.87 vs. $70.40) and above the Graham Number of $68.74, though below the growth-based intrinsic value of $121.54. Technical indicators are bearish (10/100), and insider sentiment is neutral, reflecting limited conviction despite solid dividend strength.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BNS vs BRK-B: Head-to-Head Comparison
This page compares The Bank of Nova Scotia (BNS) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.